ACE2 and COVID-19: We propose an integrative model, which incorporates both ACE2-RBD structural affinity (primarily determined by cross-species genetic difference) and epigenetic regulation of key genes during the early phase of the virus-host interaction, to predict host COVID-19 susceptibility and disease progression [30,31,32,33].